Skip to content
Certified ManufacturersFor manufacturers

LaCore Nutraceuticals Inc.

Van Alstyne, TX, United States

LaCore Nutraceuticals Inc. is a dietary supplement manufacturer in Van Alstyne, TX, United States, certified to NSF/ANSI 455-2, NSF/ANSI 455-3 and NSF/ANSI 455-4 GMP, with 1 manufacturing facility on NSF’s public NSF/ANSI 455 listing as of October 5, 2026. Listed dosage forms: capsules, liquids and powders.

Website
lacore.com
Facilities listed
1
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (1)

  • 1801 South Industrial Park, Van Alstyne, TX 75495, United States

    • Dry Formulation
    • Encapsulation
    • Liquid Formulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Warehousing

Other capsule manufacturers in the United States

  1. 21st Century Healthcare, Inc.

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Oct 5, 2026

  2. 5280 Supplement Manufacturing LLC

    Centennial, CO, United States5280smc.com

    • Capsules
    NSF/ANSI 455-2checked Oct 5, 2026

  3. Aaron Thomas Company, Inc.

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Oct 5, 2026

  4. Access Business Group, LLC

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Oct 5, 2026

  5. Adept Life Science, LLC

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    NSF/ANSI 455-2checked Oct 5, 2026

  6. ADH Health Products, Inc.

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    NSF/ANSI 455-2checked Oct 5, 2026